Adaptive orthopedic biologics
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH15C0028
- Awardee
-
The Geneva Foundation UEI TR9RX33188T4
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $3,771,694
Award facts
- Contract value 100% obligated
- $3,771,693.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Tacoma, WA 98402, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $957,264 | |
| Change Order | $0 | |
| Exercise an Option | $742,214 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $843,402 | |
| Other Administrative Action | $0 | |
| Original award | $1,228,814 |
Show all 13
About this award
This is a $3,771,693.99 firm-fixed price contract awarded by the Defense Health Agency to The Geneva Foundation, a non-profit organization, to provide adaptive orthopedic biologics research and development services. The contract was not set aside. Major subcontractors include the South Australian Health and Medical Research Institute, Akron Biotechnology, and the Cleveland Clinic Foundation, who are providing specialized expertise, production methods, and testing for the development of a combination product involving a recombinant human bone morphogenetic protein-2 (rhBMP-2) variant. This contract work supports the Defense Health Program and Uniformed Services University Medical Research Projects, which focus on advancing military medical research and development for areas like musculoskeletal injuries and novel medical countermeasures.
Quick answers
Who was awarded contract W81XWH15C0028?
W81XWH15C0028 was awarded to The Geneva Foundation by Medical Command (Department of the Army) on August 4, 2015.
How much is contract W81XWH15C0028 worth?
The government has obligated $3,771,694 on W81XWH15C0028.
Which agency awarded contract W81XWH15C0028?
Medical Command (Department of the Army) awarded W81XWH15C0028, with funding from Defense Health Agency (Department of Defense).
Was contract W81XWH15C0028 competed?
The extent of competition for W81XWH15C0028 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award